A group of 19 high-profile women in the retail and health care industries formally announced the creation of an organization called WE during a reception at the National Association of Chain Drug Stores Annual Meeting here last month. The mission of WE, derived from the first two letters in well, is
CVS Health last month named Dr. Marc-David Munk as the new chief medical officer of MinuteClinic, the company’s retail medical clinic subsidiary, as well as associate chief medical officer of CVS Health.
The role of National Association of Chain Drug Stores members in the conversation about improving health care and addressing related societal challenges was on display during the 15th Annual World Health Care Congress, held here last month.
Mike Bloom resigned late last month as chief executive officer of struggling Fred’s Inc. Secretary and chief financial officer Joseph Anto was named interim CEO. The resignation came after the chain postponed the release of its fourth quarter and 2017 full-year results.
By all accounts, opioid abuse in the U.S. has reached epidemic proportions.
Amazon.com has dropped a plan to sell pharmaceutical products to hospitals due to the project’s complexity, reported CNBC, citing sources familiar with the matter. The setback illustrates the challenges Amazon faces in getting into the medical supply and pharmaceutical space, CNBC reported.
Kevin Hourican was promoted last month to president of CVS Pharmacy, the retail division of CVS Health.
Speakers at the National Association of Chain Drug Stores Annual Meeting here last month argued that retailers need to respond to new consumer priorities and competitive pressures by embracing change while preserving and building on their traditional strengths.
Two protectionist policies being considered by the White House would result in significant job losses, according to research released by the National Retail Federation.
The National Association of Chain Drug Stores Annual Meeting last month in Palm Beach, Fla., unfolded against a backdrop of rapid-fire change in community pharmacy and the broader retailing and health care sectors.
Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis, making it the first disease-modifying therapy indicated for these patients.
Eli Lilly and Company and ARMO BioSciences, Inc. announced a definitive agreement for Lilly to acquire ARMO for $50 per share, or approximately $1.6 billion, in an all-cash transaction.
NACDS today sent the following memo to chain members: We are writing to update you on President Trump’s announcement today regarding prescription drug pricing policies, and anticipated future events related to it.
CVS Health and Walgreens have commended President Trump for vowing in a speech today to fight high drug prices.
A Lewis Drug location in Sioux Falls, SD, on Monday, May 7, 2018, made possible the screening of approximately 170 patients for skin cancer – the highest number of screenings in the nearly 20-year history of the “Melanoma Monday” event.
